Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF DESCRIPTION EQUITY METHOD INVESTMENT (Details)

v3.22.2.2
SCHEDULE OF DESCRIPTION EQUITY METHOD INVESTMENT (Details) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Equity Method Investments and Joint Ventures [Abstract]            
August 30, 2022, beginning balance $ 7,000,000          
Equity in net loss of affiliate (3,453,172) $ (3,453,172)   $ (3,453,172)    
Depreciation expense due to cost basis difference [1] (8,258) (8,258)   (8,258)    
Interest earned from convertible note receivable 5,056 5,056   5,056    
Interest earned from amortization of premium on convertible note receivable 3,621 3,621   3,621    
Elimination of intercompany interest earned (1,683) (1,683)   (1,683)    
September 30, 2022, carrying amount 3,545,564 3,545,564   3,545,564    
Equity method investment – short term (5,056) (5,056)   (5,056)  
Equity method investment – long term $ 3,540,508 3,540,508   3,540,508  
Equity in net loss of affiliate   $ (3,454,436) $ (3,454,436)  
[1] NextPlat records depreciation expense on its estimated cost basis difference which is subject to change